Research output per year
Research output per year
Personal profile
Professional Information
I am medical oncologist trained in Chile and formally trained again at the National Cancer Institute National Institutes of Health, Bethesda MD, obtaining my second oncology fellowship. Additionally, I have received direct lung cancer training from prestigious investigators such as Guiseppe Giacconne MD and medical Oncology mentorship by Antonio Fojo.
Research Interests
My main interest are immuno-oncology specific diseases such as lung cancer, renal cancer and melanoma and areas in medicine like Health policy and biostatistics. I was editor of the Seminar in Oncology journal and currently I am one of the editors of Journal of Thoracic Oncology. I have participated in more than 50 publications in indexed journals and have written several medical oncology books chapters. I am also the Medical Director of the Cancer Center of Clínica Universidad de los Andes and the Medical Director of Bradford Hill clinical research center and have participated as principal investigator in more than 30 cancer clinical trials.
External positions
Medical Director, Bradford Hill Clinical Research Center.
1 Mar 2019 → …Fingerprint
Dive into the research topics where Mauricio Burotto is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research output
-
Potential use of n-3 PUFAs to prevent oxidative stress-derived ototoxicity caused by platinum-based chemotherapy
Cortés Fuentes, I. A., Burotto, M., Retamal, M. A., Frelinghuysen, M., Caglevic, C. & Gormaz, J. G., 20 Nov 2020, In: Free Radical Biology and Medicine. 160, p. 263-276 14 p.Research output: Contribution to journal › Article › peer-review
-
Primary adrenal insufficiency during immune checkpoint inhibitor treatment: Case reports and review of the literature
Salinas, C., Renner, A., Rojas, C., Samtani, S. & Burotto, M., 1 Jan 2020, In: Case Reports in Oncology. p. 621-626 6 p.Research output: Contribution to journal › Article › peer-review
-
Recommendations for detection, prioritization, and treatment of thoracic oncology patients during the COVID-19 pandemic: the THOCOoP cooperative group
Arrieta, O., Cardona, A. F., Lara-Mejía, L., Heredia, D., Barrón, F., Zatarain-Barrón, Z. L., Lozano, F., de Lima, V. C., Maldonado, F., Corona-Cruz, F., Ramos, M., Cabrera, L., Martin, C., Corrales, L., Cuello, M., Arroyo-Hernández, M., Aman, E., Bacon, L., Baez, R., Benitez, S. & 24 others, , 1 Sep 2020, In: Critical Reviews in Oncology/Hematology. 153Research output: Contribution to journal › Scientific review › peer-review
-
Adjuvant and neoadjuvant cancer therapies: A historical review and a rational approach to understand outcomes
Burotto, M., Wilkerson, J., Stein, W. D., Bates, S. E. & Fojo, T., 1 Feb 2019, In: Seminars in Oncology. 46, 1, p. 83-99 17 p.Research output: Contribution to journal › Scientific review › peer-review
-
Developing a National Center of Excellence for Prostate Imaging
Walton-Diaz, A., Madariaga-Venegas, M., Aviles, N., Roman, J. C., Gallegos, I. & Burotto, M., 1 Oct 2019, In: Current Urology Reports. 20, 10Research output: Contribution to journal › Scientific review › peer-review
Press / Media
-
Does cytoreductive nephrectomy remain an essential component of care for advanced renal cell carcinoma?
25/06/19
1 item of Media coverage
Press/Media
-
New technique facilitates tumor detection and avoids intervention
4/06/18
1 item of Media coverage
Press/Media
-
Recurrent Respiratory Papillomatosis and Bevacizumab Treatment
2/10/17
1 item of Media coverage
Press/Media
-
-
Onxeo Announces Preclinical & Clinical Data from Three Studies Supporting the Potential For Belinostat in Multiple Orphan Oncology Indications
28/05/15
28 items of Media coverage
Press/Media